http://www.nytimes.com/2012/10/07/us/scant-drug-maker-oversight-in-meningitis-outbreak.html According to this article: “To be sure, many compounding pharmacies perform well, producing formulations of drugs for specialized needs. Compounders have also provided hospitals and doctors with cheaper alternatives to F.D.A.-approved drugs. For example, they are providing a far cheaper alternative to a drug called Makena, a new brand name version of an old […]
Filed under: General Problems | 1 Comment »